PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Clinical Immunology, Angioedema and Allergy Unit, Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel.\', \'Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.\', \'Infectious Diseases Unit, Sheba Medical Center, Tel Hashomer, Israel.\', \'Infection Prevention and Control Unit, Sheba Medical Center, Israel.\', \'Sheba Medical Center, Tel Hashomer, Israel.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1001/jamanetworkopen.2021.22255
?:hasPublicationType
?:journal
  • JAMA network open
is ?:pmid of
?:pmid
?:pmid
  • 34463744
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all